With the help of data provided by the National Venture Capital Association, our sister pub FierceBiotech has put together a list of last year's top biotech venture capital deals. 2009 was an incredibly difficult year for biotech companies to raise venture funding, as the financial crisis caused firms to become more cautious with their money. But for companies with groundbreaking technology and exciting programs, there was still money to be had. Take a look at this list of the top 20 U.S. companies that raised big money in 2009. Report